b
r
c
innat
immun
system
possess
multitud
pathway
sens
respond
microbi
pathogen
one
famili
interferon
ifn
famili
cytokin
involv
sever
cellular
function
type
ifn
appreci
import
sever
viral
bacteri
diseas
recent
identifi
type
iii
ifn
studi
primarili
context
viral
infect
viral
bacteri
infect
howev
mutual
exclus
often
presenc
viral
pathogen
increas
pathogenesi
bacteri
infect
role
type
iii
ifn
bacteri
viralbacteri
coinfect
begun
explor
mini
review
discuss
type
iii
ifn
signal
role
microbi
pathogenesi
emphasi
work
conduct
bacteri
pathogen
advent
antibioticera
promis
significantli
reduc
incid
neg
outcom
associ
infecti
diseas
howev
pathogen
bacteria
still
play
signific
role
live
infecti
diseas
one
common
worldwid
caus
death
lead
caus
diseas
burden
assess
disabilityadjustedlifeyear
world
health
organ
grow
number
antimicrobi
resist
bacteria
increas
concern
prompt
releas
report
global
burden
antimicrobi
resist
high
level
resist
present
common
pathogen
caus
healthcar
communityacquir
infect
one
way
potenti
combat
resist
organ
gain
better
understand
innat
immun
host
pathway
involv
clearanc
aim
potenti
modul
signal
activ
improv
clearanc
reduc
host
damag
interferon
famili
cytokin
perform
varieti
immun
cellular
function
type
interferon
ifn
famili
cytokin
consist
ifna
subtyp
ifnb
ifn
ifnv
type
ii
ifn
famili
repres
ifng
initi
identifi
type
iii
ifn
famili
ifnl
consist
discov
sheppard
kotenko
recent
type
iii
ifn
famili
expand
identifi
genet
studi
patient
infect
hepat
c
viru
origin
thought
pseudogen
becam
clear
signific
percentag
human
popul
function
gene
singl
nucleotid
polymorph
snp
major
popul
result
frameshift
mutat
inhibit
product
high
sequenc
ident
type
iii
interferon
famili
member
approxim
interestingli
type
iii
ifn
famili
close
relat
oppos
either
type
type
ii
ifn
explain
initi
name
part
interleukin
famili
gene
ifn
lambda
famili
contain
four
intron
like
type
ifn
gene
contain
intron
type
iii
ifn
amino
acid
similar
type
ifn
famili
respect
type
iii
ifn
induc
respons
rang
viral
bacteri
stimuli
almost
complet
overlap
type
ifn
pathway
type
iii
ifn
signal
tradit
associ
viral
infect
appreci
bacteria
product
also
abl
activ
pathway
mani
bacteri
pathogen
intraand
extracellular
abl
induc
type
ifn
respons
via
recognit
pamp
messeng
dna
rna
peptidoglycan
lp
cyclic
diadenosin
monophosph
cdiamp
nod
rna
polymeras
iii
stimul
interferon
gene
sting
among
mani
sensor
involv
activ
ifn
respons
similarli
divers
pathogen
activ
type
iii
ifn
respons
appear
type
vs
type
iii
balanc
signal
mediat
cellular
locat
receptor
receptor
activ
pathway
current
dna
sensor
identifi
receptor
capabl
activ
type
iii
type
ifn
type
iii
ifn
signal
receptor
dimer
consist
respond
exclus
type
iii
ifn
share
famili
member
rais
interest
current
unaddress
question
potenti
regul
signal
type
iii
ifn
visa
versa
ifnl
signal
thought
inhibit
enhanc
also
signal
unclear
influenc
ifnl
signal
receptor
sequestr
affect
interferon
signal
pathway
bind
ifnl
dimer
induc
jakstat
signal
fig
similar
type
ifn
signal
result
express
interferon
respons
gene
gene
integr
searchabl
databas
known
interferom
v
http
interferomeitsmonasheduau
inform
databas
identifi
two
thousand
interferon
regul
gene
irg
use
identifi
specif
interferon
gene
signatur
associ
particular
diseas
state
speci
microbi
infect
type
type
iii
pathway
activ
similar
gene
set
signific
differ
pathway
first
foremost
tissu
express
ifnar
differ
significantli
ifnar
ubiquit
express
express
restrict
subset
cell
type
primarili
epitheli
cell
keratinocyt
howev
dendrit
cell
neutrophil
popul
also
report
respond
type
iii
ifn
specif
local
ifnl
receptor
may
allow
tightli
regul
immun
respons
express
signal
inhibitor
like
suppressor
cytokin
signal
soc
protein
resid
cell
epithelium
time
maintain
immun
activ
ifnl
insensit
hematopoiet
cell
popul
type
ifn
induc
signal
suppress
cell
perhap
result
immun
toler
type
iii
ifn
induct
kinet
also
differ
type
ifn
type
ifn
induc
rapid
higher
magnitud
respons
compar
type
iii
ifn
type
iii
ifn
induc
sustain
respons
gene
induct
influenza
induc
robust
type
iii
ifn
respons
epitheli
cell
stat
activ
type
iii
ifn
significantli
prolong
compar
respons
type
ifn
type
ifn
induct
downstream
gene
depend
interferon
regulatori
factor
irf
depend
interferonrespons
sequenc
element
irs
transcript
factor
antivir
signal
downstream
type
iii
ifn
partial
depend
nfkb
mapk
signal
activ
could
explain
human
airway
epitheli
cultur
type
ifn
signal
primari
contributor
antivir
signal
respons
rsv
recent
transcript
factor
shown
select
upregul
type
iii
type
ifn
type
iii
ifn
select
downregul
therefor
type
iii
ifn
famili
capabl
activ
gene
ifn
famili
restrict
receptor
express
depend
signal
pathway
optim
gene
induct
limit
influenc
type
iii
ifn
immun
howev
activ
type
iii
ifn
famili
prolong
role
host
defens
role
type
iii
ifn
human
diseas
yet
complet
understood
howev
initi
studi
uncov
associ
mutat
respons
hepat
c
viru
polymorph
upstream
predict
respons
chronic
infect
hepat
c
viru
hcv
patient
type
ifn
therapi
polymorph
also
correl
natur
clearanc
viru
addit
polymorph
ttdg
found
even
better
predictor
hcv
clearanc
due
increas
express
glaxosmithklin
current
develop
ifnl
therapi
base
find
hypothesi
treatment
boost
clearanc
hcv
reduc
neg
side
effect
associ
peg
ifn
type
ifn
therapi
due
limit
locat
ifnl
receptor
express
diseas
link
excess
activ
type
ifn
term
interferonopathi
first
identifi
syndrom
ag
inflammatori
disord
brain
skin
patient
exhibit
rais
interferon
level
type
ifn
gene
signatur
exampl
includ
savi
stingassoci
vasculopathi
onset
infanc
global
proteosom
disord
chronic
atyp
neutrophil
dermatosi
lipodystrophi
elev
temperatur
candl
well
spondyloenchondrodysplasia
system
lupu
erythematosu
complement
defici
also
identifi
interferonopathi
ifn
signal
link
exacerb
asthmat
invers
correl
ifnl
sever
allerg
asthma
human
report
diseas
associ
type
ifn
howev
type
type
iii
ifn
activ
downstream
gene
contribut
type
iii
ifn
diseas
rule
much
earli
work
toward
identifi
role
type
iii
ifn
infecti
diseas
focus
viral
infect
interferon
knockout
mice
vitro
experiment
system
develop
better
understand
immun
implic
type
iii
ifn
data
gener
util
model
data
suggest
potenti
role
type
iii
ifn
cancer
autoimmun
review
detail
recent
articl
lazear
et
al
therefor
briefli
summar
vast
major
research
focus
contribut
type
iii
ifn
antivir
host
defens
mice
type
iii
ifn
produc
significantli
higher
level
type
ifn
respons
influenza
viru
produc
type
iii
ifn
abl
protect
mice
sever
influenza
infect
even
ifnar
mice
presenc
either
function
type
type
iii
ifn
pathway
suffici
mount
host
defens
respons
influenza
infect
increas
viral
titer
observ
mice
lack
type
type
iii
ifn
receptor
well
mice
type
type
iii
ifn
pathway
inhibit
similarli
clearanc
sarscov
found
depend
type
ii
iii
ifn
receptor
suggest
pathway
compens
respons
viral
pathogen
host
defens
virus
murin
system
depend
type
iii
ifn
pathway
exampl
herp
simplex
viru
hsv
clearanc
requir
activ
type
iii
ifn
system
elimin
murin
noroviru
requir
ifn
lambda
treatment
type
iii
ifn
also
progress
treatment
viral
infect
phase
studi
patient
chronic
hepat
c
show
improv
viral
suppress
fewer
side
effect
type
iii
versu
type
ifn
therapi
unclear
depend
type
iii
ifn
differ
viral
infect
howev
could
due
type
cell
involv
clear
infect
rel
level
type
iii
ifn
receptor
express
type
iii
ifn
also
implic
antibacteri
immun
respons
type
iii
pathway
first
shown
activ
live
salmonella
enterica
typhimurium
purifi
lipopolysaccharid
lp
human
dendrit
cell
induct
type
iii
ifn
correl
l
monocytogen
clearanc
lebreton
et
al
demonstr
listeria
virul
factor
lnta
target
chromatin
repressor
prevent
interact
interferon
stimul
gene
isg
therefor
increas
interferon
signal
studi
first
indic
bacteria
could
activ
type
iii
ifn
pathway
bacteri
virul
factor
modul
chromatin
remodel
affect
pathway
date
one
studi
directli
test
contribut
type
iii
ifn
clearanc
bacteri
pathogen
studi
aureu
p
aeruginosa
found
activ
type
iii
ifn
signal
lung
organ
activ
type
iii
ifn
differ
degre
either
case
loss
type
iii
ifn
receptor
improv
bacteri
clearanc
reduc
lung
patholog
acut
infect
contribut
type
iii
ifn
clearanc
bacteri
pathogen
directli
studi
howev
attempt
extend
result
studi
aim
type
ifn
pathway
result
summar
see
tabl
typhimurium
shown
activ
type
iii
ifn
product
typhimurium
activ
robust
type
iii
ifn
respons
phagocyt
cell
dendrit
cell
intestin
epitheli
cell
activ
type
iii
ifn
signal
typhimurium
occur
live
heatkil
organ
well
via
purifi
lp
akin
type
ifn
respons
vitro
respons
human
cell
typhimurium
occur
rapidli
within
h
infect
maintain
h
period
transcript
still
occur
even
presenc
protein
synthesi
inhibitor
gain
better
understand
pathway
pietila
et
al
show
type
iii
ifn
product
inhibit
inhibitor
kinas
nfkb
erk
jnk
kinas
interferon
stimul
gene
also
inhibit
consist
lp
induc
activ
pbmcperipher
blood
mononuclear
cell
bmdcbone
marrow
deriv
dendrit
cell
modchuman
monocyt
deriv
dendrit
cell
cfcystic
fibrosi
nanot
analyzedunknown
type
iii
ifn
inhibit
dynamindepend
endocytosi
abolish
secret
presum
interf
triftram
signal
known
type
ifn
play
inhibitori
role
infect
role
yet
identifi
salmonella
infect
listeria
monocytogen
one
origin
organ
studi
context
bacteri
activ
type
ifn
remain
heavili
studi
area
recent
type
iii
ifn
field
type
iii
ifn
induct
l
monocytogen
far
shown
occur
intestin
epitheli
cell
hepatocyt
placent
trophoblast
induct
observ
hek
cell
activ
type
iii
ifn
intestin
epitheli
cell
occur
multipl
stage
initi
induct
occur
bacteria
intern
later
phase
correspond
escap
vacuol
intern
l
monocytogen
henc
type
iii
ifn
induct
requir
express
invas
protein
lnla
lnlb
listeriolysin
mediat
escap
cytosol
also
requir
type
iii
ifn
induc
l
monocytogen
produc
anoth
secret
factor
directli
effect
type
iii
ifn
product
lnta
listeria
nuclear
target
protein
protein
abl
target
protein
cell
nucleu
chromatin
repressor
capabl
repress
interferon
stimul
gene
isg
intestin
epitheli
cell
abl
activ
type
iii
ifn
stimul
l
monocytogen
absenc
lnta
normal
condit
target
lnta
facilit
product
type
iii
ifn
role
lnta
type
iii
ifn
infect
perfect
exampl
pathogen
fine
tune
express
virul
factor
inactiv
lnta
lead
improv
clearanc
anim
model
constitut
express
lnta
lead
higher
type
iii
product
also
lead
enhanc
clearanc
rigi
like
receptor
rlr
involv
type
iii
induct
l
monocytogen
signal
via
rlr
adaptor
protein
mitochondri
antivir
signal
mav
suffici
type
iii
ifn
induct
specif
mav
present
signal
organel
peroxisom
suffici
signal
role
type
iii
infect
l
monocytogen
test
vivo
activ
type
iii
ifn
shown
model
fetoplacent
listeriosi
well
induct
interferon
respons
gene
abil
tuberculosi
activ
type
iii
ifn
observ
clinic
comparison
sputum
healthi
latent
activ
infect
patient
show
significantli
higher
level
type
iii
ifn
activ
infect
sampl
level
also
correl
well
bacteri
load
present
sputum
abil
tuberculosi
induc
type
iii
ifn
corrobor
observ
patient
initi
therapi
reduc
bacteri
load
led
reduc
level
signal
involv
type
iii
ifn
induct
tuberculosi
yet
investig
observ
activ
type
iii
ifn
cell
vitro
hope
greater
understand
type
iii
ifn
signal
prove
use
type
ifn
signal
type
ifn
signatur
identifi
tuberculosi
detect
activ
infect
patient
latent
infect
present
excel
diagnost
potenti
caus
agent
lyme
diseas
borrelia
burgdorferi
induc
type
iii
ifn
product
similar
manner
type
ifn
type
ifn
induc
nucleic
acid
dna
rna
monocyt
type
iii
ifn
shown
induc
live
organ
purifi
rna
human
peripher
blood
mononuclear
cell
abil
induc
type
iii
ifn
appear
correl
clinic
isol
clinic
isol
typic
induc
much
robust
interferon
type
iii
respons
isol
less
frequent
associ
infect
abil
b
burgdorferi
activ
type
iii
ifn
appear
depend
plasmid
strain
lack
plasmid
reduc
adher
uptak
phagocyt
ultim
lead
blunt
type
iii
ifn
respons
physiolog
signific
type
iii
ifn
pathway
b
burgdorferi
pathogenesi
yet
determin
aureu
abl
differenti
activ
interferon
varieti
receptor
transcript
factor
precis
receptor
involv
activ
type
iii
ifn
known
much
learn
use
knockout
mice
aureu
abl
activ
type
iii
ifn
myeloid
stromal
cell
aliv
heat
kill
prompt
activ
observ
vivo
model
acut
pneumonia
mice
lack
significantli
improv
outcom
infect
improv
bacteri
clearanc
airway
lung
tissu
improv
pulmonari
patholog
reduc
proinflammatori
cytokin
product
compar
equal
infect
control
mice
one
cytokin
reduc
model
antagon
vivo
improv
clearanc
aureu
also
observ
type
ifn
known
influenc
activ
influenc
proinflammatori
cytokin
product
regul
cohen
et
al
show
increas
infect
concomitantli
reduc
attribut
reduc
cytokin
product
observ
mice
result
mice
lack
also
improv
outcom
aureu
infect
data
provid
evid
host
pathway
neg
contribut
bacteri
pathogenesi
role
type
iii
ifn
p
aeruginosa
infect
similar
describ
aureu
p
aeruginosa
abl
rapidli
activ
type
iii
ifn
product
dendrit
cell
epitheli
cell
vivo
level
declin
baselin
h
infect
lung
induct
type
iii
ifn
observ
decreas
cystic
fibrosi
compar
control
airway
epitheli
cell
mice
intranas
infect
p
aeruginosa
abl
effect
clear
infect
airway
lung
tissu
associ
improv
pulmonari
patholog
reduct
proinflammatori
cytokin
product
observ
aureu
cohen
et
al
found
increas
decreas
infect
mice
compar
wildtyp
mice
addit
mechan
explain
abil
type
iii
ifn
signal
aid
bacteri
persist
biofilm
format
vitro
cell
cultur
model
respiratori
syncyti
viru
rsv
infect
observ
increas
p
aeruginosa
biofilm
format
biofilm
format
shown
type
type
iii
ifn
depend
knockdown
antibodi
neutral
receptor
reduc
p
aeruginosa
biofilm
format
presenc
rsv
infect
sever
bacteri
speci
studi
shown
induc
type
iii
ifn
lactococcu
lacti
epidermidi
enterococcu
howev
extent
known
abil
activ
pathway
histori
influenza
suggest
secondari
bacteri
infect
significantli
contribut
mortal
associ
sever
influenza
infect
review
detail
origin
bacteri
coinfect
observ
lung
tissu
save
victim
influenza
pandem
principl
bacteria
found
lung
sampl
pneumonia
aureu
h
influenza
morbid
morbid
subsequ
influenza
pandem
also
correl
presenc
coinfect
bacteri
pathogen
aureu
emerg
common
coinfect
pathogen
aureu
especi
strain
associ
sever
influenza
associ
pneumonia
contribut
emerg
aureu
vaccin
reduc
occurr
h
influenza
type
b
pneumonia
therefor
rate
coinfect
bacteria
drop
rate
aureu
coinfect
increas
specif
multidrug
resist
mrsa
strain
murin
studi
influenza
associ
bacteri
infect
also
demonstr
interferon
signal
contribut
enhanc
diseas
associ
infect
type
ii
interferon
act
resid
macrophag
lung
suppress
express
surfac
protein
marco
essenti
phagocytosi
bacteria
type
interferon
appear
influenc
role
sever
immun
function
model
superinfect
type
ifn
implic
develop
aureu
pneumonia
superinfect
impair
antibacteri
host
defenc
type
interferon
occur
decreas
product
inhibit
antimicrobi
pathway
worth
note
studi
analys
type
ifn
pathway
bacteri
superinfect
examin
role
type
iii
ifn
quit
possibl
due
parallel
natur
pathway
type
iii
ifn
also
contribut
enhanc
diseas
phenotyp
addit
retrospect
studi
pandem
influenza
infect
evid
emerg
associ
live
attenu
influenza
vaccin
bacteri
nasal
carriag
live
attenu
influenza
vaccin
found
enhanc
carriag
level
pneumonia
aureu
nasopharynx
likewis
human
vaccin
administr
found
alter
nasal
microbiom
increas
ifn
gene
signatur
elev
carriag
staphylococc
speci
studi
interferon
induct
respons
increas
suscept
bacteri
infect
murin
model
induct
ifn
signal
poli
c
result
increas
bacteri
carriag
influenza
infect
also
shown
increas
restructur
mous
nasal
microbiom
mani
case
overal
divers
remain
unchang
increas
commens
staphylococci
observ
chang
microbiota
shown
type
iii
ifn
depend
influenza
infect
mice
also
suscept
aureu
colon
subsequ
aspir
organ
lung
suscept
depend
upon
type
iii
ifn
signal
model
acut
aureu
lung
infect
postinfluenza
mice
previous
infect
influenza
higher
bacteri
burden
lung
reduc
absenc
type
iii
ifn
signal
therefor
type
iii
ifn
pathway
promot
colon
airway
subsequ
infect
lower
airway
although
recent
discov
compar
rest
interferon
famili
type
iii
ifn
alreadi
shown
play
role
viral
bacteri
infect
type
iii
ifn
therapi
undergo
clinic
trial
hepat
c
infect
polymorph
human
predict
improv
outcom
therapi
type
iii
ifn
induc
similar
repertoir
gene
type
ifn
prolong
period
time
sever
studi
identifi
bacteri
pathogen
activ
type
iii
ifn
clinic
data
use
knockout
mice
identifi
sever
pathogen
appear
flourish
type
iii
ifn
induc
data
indic
type
iii
ifn
signal
novel
pathway
potenti
host
immunomodul
era
antibiot
resist
increas
concern
exuber
host
respons
contribut
morbid
mortal
